Elixinol Wellness Ltd (ASX: EXL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Elixinol Wellness Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$7.80 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
1.32 billion
Earnings per share
-0.008
Dividend per share
N/A
Year To Date Return
-46.43%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Elixinol Wellness Ltd (ASX: EXL)
Latest News
Share Fallers
Cannabis company Elixinol Global posts 19% increase in half year revenue to $18.3 million
Growth Shares
3 ASX growth shares on my September watchlist
Share Market News
Should you still be invested in ASX marijuana shares?
⏸️ Investing
Which ASX growth shares to invest $10,000 in August
Share Market News
3 ASX cannabis shares to keep your eye on
Share Market News
Cannabis company Elixinol Global announces supply agreement with Pet Releaf
Share Gainers
Elixinol Global share price pushes higher on second quarter update
Share Market News
Is this ASX cannabis stock a buy after acquisition news?
Share Market News
Is the Ecofibre share price a buy?
Share Gainers
ALL ORDINARIES finishes higher Wednesday: 8 shares you missed
Share Gainers
Cannabis company Elixinol Global granted manufacturing licence
Share Market News
High profile fundie warns these 10 ASX shares have "bubble" valuations
EXL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Elixinol Wellness Ltd
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the three operating segments of the Americas, Australia, Rest of the World regions of which key revenue is derived from the Australia segment. The Australia segment includes the results from operations of Elixinol Wellness (Byron Bay) Pty Ltd and The Sustainable Nutrition Group Pty Ltd and its subsidiaries.
EXL Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 21 Nov 2024 | $0.01 | $0.00 | 0.00% | 733,614 | $0.01 | $0.01 | $0.01 |
| 20 Nov 2024 | $0.01 | $0.00 | 0.00% | 16,942,535 | $0.01 | $0.01 | $0.01 |
| 19 Nov 2024 | $0.01 | $0.00 | 0.00% | 321,336 | $0.01 | $0.01 | $0.01 |
| 18 Nov 2024 | $0.01 | $0.00 | 0.00% | 8,867,028 | $0.01 | $0.01 | $0.01 |
| 15 Nov 2024 | $0.01 | $0.00 | 0.00% | 10,226,428 | $0.01 | $0.01 | $0.00 |
| 14 Nov 2024 | $0.00 | $0.00 | 0.00% | 10,354,901 | $0.00 | $0.00 | $0.00 |
| 13 Nov 2024 | $0.00 | $0.00 | 0.00% | 107,650 | $0.00 | $0.00 | $0.00 |
| 12 Nov 2024 | $0.00 | $0.00 | 0.00% | 19,247 | $0.00 | $0.00 | $0.00 |
| 11 Nov 2024 | $0.00 | $0.00 | 0.00% | 1,460,087 | $0.00 | $0.00 | $0.00 |
| 07 Nov 2024 | $0.00 | $0.00 | 0.00% | 1,404,496 | $0.00 | $0.00 | $0.00 |
| 06 Nov 2024 | $0.00 | $0.00 | 0.00% | 146,731 | $0.00 | $0.00 | $0.00 |
| 05 Nov 2024 | $0.00 | $0.00 | 0.00% | 309,868 | $0.00 | $0.00 | $0.00 |
| 04 Nov 2024 | $0.00 | $0.00 | 0.00% | 550,584 | $0.00 | $0.00 | $0.00 |
| 01 Nov 2024 | $0.00 | $0.00 | 0.00% | 570,128 | $0.00 | $0.00 | $0.00 |
| 31 Oct 2024 | $0.00 | $0.00 | 0.00% | 30,551 | $0.00 | $0.00 | $0.00 |
| 30 Oct 2024 | $0.00 | $0.00 | 0.00% | 4,878,868 | $0.00 | $0.00 | $0.00 |
| 28 Oct 2024 | $0.00 | $0.00 | 0.00% | 296,053 | $0.00 | $0.00 | $0.00 |
| 25 Oct 2024 | $0.00 | $0.00 | 0.00% | 485 | $0.00 | $0.00 | $0.00 |
| 24 Oct 2024 | $0.00 | $0.00 | 0.00% | 2,507,927 | $0.00 | $0.01 | $0.00 |
| 23 Oct 2024 | $0.00 | $0.00 | 0.00% | 1,345,491 | $0.00 | $0.00 | $0.00 |
| 22 Oct 2024 | $0.00 | $0.00 | 0.00% | 3,438,608 | $0.00 | $0.00 | $0.00 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 31 May 2024 | David (Dave) Fenlon | Issued | 3,752,345 | $19,999 |
Director remuneration. 4,218,098 rIGHTS
|
| 08 Apr 2024 | Natalie Butler | Exercise | 874,000 | $5,244 |
Conversion of securities. 874,000 performance rights
|
| 08 Apr 2024 | Natalie Butler | Issued | 874,000 | $5,244 |
Conversion of securities.
|
| 28 Mar 2024 | Ron Dufficy | Expiry | 3,171,994 | $15,859 |
As advised by the company. Lapsed
|
| 28 Mar 2024 | David (Dave) Fenlon | Expiry | 1,250,000 | $6,250 |
As advised by the company. 465,753 Rights, lapsed
|
| 06 Feb 2024 | Ron Dufficy | Expiry | 548,077 | $5,480 |
As advised by the company. Lapsing of Performance Share rights,31,71,994 Rights
|
| 23 Nov 2023 | David (Dave) Fenlon | Issued | 625,000 | $8,750 |
Issue of options.
|
| 23 Nov 2023 | David (Dave) Fenlon | Exercise | 625,000 | $8,750 |
Conversion of securities. 17,15,753 Rights
|
| 23 Nov 2023 | David (Dave) Fenlon | Issued | 625,000 | $8,750 |
Conversion of securities.
|
| 23 Nov 2023 | Ron Dufficy | Issued | 902,778 | $12,638 |
Conversion of securities.
|
| 23 Nov 2023 | Ron Dufficy | Buy | 902,778 | $12,638 |
Issue of options.
|
| 23 Nov 2023 | Ron Dufficy | Exercise | 902,778 | $12,638 |
Conversion of securities. 37,20,071 Rights
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr David (Dave) Fenlon | Non-Executive DirectorNon-Executive Chairman | Mar 2022 |
Mr David has worked with retail brands both in Australia and offshore, with a focus on strategic planning and business transformation including in key positions with Tesco throughout Europe and Safeway in the UK. David was a member of the Board of Directors for the Special Olympics from May 2017 until June 2019. Fenlon has over 30 years of experience in the FMCG and consumer sectors. He is member of Risk Committee.
|
| Ms Pauline Therese Gately | Non-Executive Director | Aug 2023 |
Ms Gately is a director who brings a commercial focus to strategy with demonstrated achievement in funding, business development, and strategic transformation having led companies through IPO, business recalibration and mergers and acquisitions. Her Board contributions are also underpinned by senior roles in international investment banking across the Asia Pacific region. She is chair of Risk Committee.
|
| Ms Natalie Butler | Non-Executive Director | Mar 2024 |
--
|
| Ms Melanie Jaye Leydin | Company Secretary | Jul 2024 |
-
|
| Melanie Jaye Leydin | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Cg Nominees (Australia) Pty Ltd | 31,074,072 | 4.91% |
| UBS Nominees Pty Ltd | 20,945,417 | 3.31% |
| Hsbc Custody Nominees (Australia) Limited | 18,698,448 | 2.95% |
| Citicorp Nominees Pty Limited | 18,181,816 | 2.87% |
| Rosedale Super Pty Ltd (Rosedale Super Fund A/C) | 16,871,048 | 2.67% |
| Raw With Life Pty Ltd (Benhaim Trading A/C) | 16,692,881 | 2.64% |
| James Robert Hood Pty Ltd (Bluestone A/C) | 11,387,115 | 1.80% |
| Mr Stuart Reseck & Mrs Nicole Deanne Reseck (Reseck Super Fund A/C) | 11,000,000 | 1.74% |
| Ms Pauline Therese Gately | 9,930,583 | 1.57% |
| Interdale Pty Ltd (Maple Super A/C) | 7,035,496 | 1.11% |
| Mr Kieran John O'Brien | 6,021,500 | 0.95% |
| Mr Ashley Hardwick | 5,402,778 | 0.85% |
| Jasforce Pty Ltd | 5,049,873 | 0.80% |
| Mr Ronald Michael Dufficy | 4,814,835 | 0.76% |
| Bnp Paribas Nominees Pty Ltd Acf Clearstream | 4,539,590 | 0.72% |
| Cotton On Innovation Fund Pty Ltd | 4,472,461 | 0.71% |
| D & G Health Llc | 4,119,229 | 0.65% |
| Kaneden Enterprises Pty Ltd (Roseburgh Family Super A/C) | 4,000,000 | 0.63% |
| Mr Nicky Alfred Kleyn | 4,000,000 | 0.63% |
| Cotton On Innovation Fund Pty Ltd i | 3,928,750 | 0.62% |
